Insufficient scRNA-seq data for expression of USP6 at single-cell level.
Insufficient scRNA-seq data for expression of USP6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 97% | 1241.49 | 174 / 180 | 9% | 0.20 | 40 / 430 |
| thymus | 85% | 499.07 | 558 / 653 | 15% | 0.38 | 90 / 605 |
| muscle | 100% | 4897.51 | 801 / 803 | 0% | 0 | 0 / 0 |
| prostate | 80% | 392.71 | 195 / 245 | 3% | 0.05 | 17 / 502 |
| breast | 69% | 505.34 | 318 / 459 | 5% | 0.10 | 56 / 1118 |
| brain | 63% | 143.02 | 1652 / 2642 | 11% | 0.44 | 80 / 705 |
| spleen | 66% | 191.78 | 159 / 241 | 0% | 0 | 0 / 0 |
| kidney | 51% | 246.64 | 45 / 89 | 7% | 0.20 | 59 / 901 |
| uterus | 46% | 368.28 | 79 / 170 | 8% | 0.26 | 37 / 459 |
| lung | 46% | 216.49 | 265 / 578 | 3% | 0.06 | 32 / 1155 |
| adipose | 44% | 261.94 | 530 / 1204 | 0% | 0 | 0 / 0 |
| skin | 31% | 146.94 | 554 / 1809 | 6% | 0.16 | 28 / 472 |
| intestine | 34% | 308.84 | 331 / 966 | 1% | 0.01 | 4 / 527 |
| bladder | 29% | 232.14 | 6 / 21 | 2% | 0.05 | 9 / 504 |
| esophagus | 24% | 242.84 | 342 / 1445 | 3% | 0.04 | 6 / 183 |
| stomach | 18% | 113.86 | 64 / 359 | 2% | 0.03 | 6 / 286 |
| pancreas | 16% | 78.51 | 52 / 328 | 3% | 0.04 | 5 / 178 |
| blood vessel | 18% | 104.04 | 238 / 1335 | 0% | 0 | 0 / 0 |
| adrenal gland | 16% | 37.33 | 41 / 258 | 1% | 0.02 | 2 / 230 |
| heart | 16% | 120.27 | 136 / 861 | 0% | 0 | 0 / 0 |
| liver | 9% | 17.84 | 20 / 226 | 0% | 0.01 | 2 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 0.20 | 3 / 45 |
| peripheral blood | 4% | 30.54 | 40 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 4% | 0.05 | 3 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0060627 | Biological process | regulation of vesicle-mediated transport |
| GO_0016579 | Biological process | protein deubiquitination |
| GO_0036211 | Biological process | protein modification process |
| GO_0006508 | Biological process | proteolysis |
| GO_0099149 | Biological process | regulation of postsynaptic neurotransmitter receptor internalization |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0005764 | Cellular component | lysosome |
| GO_0055037 | Cellular component | recycling endosome |
| GO_0099092 | Cellular component | postsynaptic density, intracellular component |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005516 | Molecular function | calmodulin binding |
| GO_0004197 | Molecular function | cysteine-type endopeptidase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0003676 | Molecular function | nucleic acid binding |
| GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
| Gene name | USP6 |
| Protein name | Ubiquitin carboxyl-terminal hydrolase 6 (EC 3.4.19.12) (Deubiquitinating enzyme 6) (Proto-oncogene TRE-2) (RN-tre) (Ubiquitin thioesterase 6) (Ubiquitin-specific-processing protease 6) Oncogene (Ubiquitin specific peptidase 6) Alternative protein USP6 |
| Synonyms | tre HRP1 TRE2 |
| Description | FUNCTION: Deubiquitinase with an ATP-independent isopeptidase activity, cleaving at the C-terminus of the ubiquitin moiety. Catalyzes its own deubiquitination. In vitro, isoform 2, but not isoform 3, shows deubiquitinating activity. Promotes plasma membrane localization of ARF6 and selectively regulates ARF6-dependent endocytic protein trafficking. Is able to initiate tumorigenesis by inducing the production of matrix metalloproteinases following NF-kappa-B activation. May act as a GTPase-activating protein for RAB3A . . |
| Accessions | ENST00000574788.6 [P35125-1] P35125 Q15635 L8E827 ENST00000575709.5 ENST00000572949.5 [P35125-3] ENST00000250066.6 [P35125-1] |